1. Home
  2. AFJK vs DERM Comparison

AFJK vs DERM Comparison

Compare AFJK & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFJK
  • DERM
  • Stock Information
  • Founded
  • AFJK 2023
  • DERM 2014
  • Country
  • AFJK United States
  • DERM United States
  • Employees
  • AFJK N/A
  • DERM N/A
  • Industry
  • AFJK
  • DERM Biotechnology: Pharmaceutical Preparations
  • Sector
  • AFJK
  • DERM Health Care
  • Exchange
  • AFJK NYSE
  • DERM Nasdaq
  • Market Cap
  • AFJK 96.8M
  • DERM 87.4M
  • IPO Year
  • AFJK 2023
  • DERM 2021
  • Fundamental
  • Price
  • AFJK $10.75
  • DERM $3.66
  • Analyst Decision
  • AFJK
  • DERM Strong Buy
  • Analyst Count
  • AFJK 0
  • DERM 3
  • Target Price
  • AFJK N/A
  • DERM $9.50
  • AVG Volume (30 Days)
  • AFJK 59.0K
  • DERM 63.2K
  • Earning Date
  • AFJK 01-01-0001
  • DERM 11-12-2024
  • Dividend Yield
  • AFJK N/A
  • DERM N/A
  • EPS Growth
  • AFJK N/A
  • DERM N/A
  • EPS
  • AFJK 0.29
  • DERM N/A
  • Revenue
  • AFJK N/A
  • DERM $57,771,000.00
  • Revenue This Year
  • AFJK N/A
  • DERM N/A
  • Revenue Next Year
  • AFJK N/A
  • DERM $36.49
  • P/E Ratio
  • AFJK $36.60
  • DERM N/A
  • Revenue Growth
  • AFJK N/A
  • DERM N/A
  • 52 Week Low
  • AFJK $10.80
  • DERM $2.85
  • 52 Week High
  • AFJK $10.85
  • DERM $6.89
  • Technical
  • Relative Strength Index (RSI)
  • AFJK N/A
  • DERM 29.46
  • Support Level
  • AFJK N/A
  • DERM $3.54
  • Resistance Level
  • AFJK N/A
  • DERM $4.00
  • Average True Range (ATR)
  • AFJK 0.00
  • DERM 0.36
  • MACD
  • AFJK 0.00
  • DERM -0.01
  • Stochastic Oscillator
  • AFJK 0.00
  • DERM 12.77

About AFJK AIMEI HEALTH TECHNOLOGY CO LTD

Aimei Health Technology Co Ltd is a blank check company.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Share on Social Networks: